Where is trazodone made?

Who manufactures trazodone and where is it made?

Trazodone is a prescription medication primarily used to treat depression and, in some cases, insomnia. It was first approved by the US FDA in 1981 under the brand name Desyrel, manufactured by Wyeth (now a part of Pfizer). [1]

Current manufacturers and production locations

Today, trazodone is manufactured and distributed by various pharmaceutical companies worldwide. Some of the notable companies that produce generic trazodone include:

- Teva Pharmaceuticals (Israel): Teva Pharmaceuticals has a significant presence in Israel and has been manufacturing generic trazodone for several years.
- Mylan (India): Mylan, a multinational pharmaceutical company with a major presence in India, also produces generic trazodone.
- Sandoz (Switzerland): Sandoz, the generic pharmaceutical division of Novartis, also manufactures generic trazodone.
- Apotex (Canada): Apotex, a Canadian pharmaceutical company, produces generic trazodone.

Generic availability and patent expiry

As of 2023, multiple generic versions of trazodone are available in the US and many other countries, indicating that the original patent has expired or is expiring soon. According to DrugPatentWatch.com, the patent for trazodone is set to expire in certain countries in 2024 and 2025. [2]

Important note

Please consult your healthcare provider or local pharmacy to confirm the manufacturer and quality of the trazodone product you receive, as production locations and manufacturers can change over time.

Additional resources:

- DrugPatentWatch.com (for patent information)
- FDA.gov (for regulatory information on trazodone)
- Manufacturer websites (for product information and location of production facilities)

References:

[1] FDA.gov: Trazodone Approval History (accessed 2023).
[2] DrugPatentWatch.com: Trazodone Patent Expiry Dates (accessed 2023).